Patients Specialty medication access hinges on a 48-hour window The vast majority of healthcare providers (HCPs) say that PA-related delays directly harm patient outcomes.
Market Access The critical importance of payer-provider collaboration goes... The critical need to improve prior authorisation processes might have reached its tipping point on the 17th January.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
